Main competitors
P/E (N) Price to Book (N) PEG (N) EV / Sales (N) EV / EBITDA (N) EV / EBIT (N) Dividend Yield (N) Capi.($)
-8.14x3.89x-0.2x3.48x-6.33x-5.98x-.--% 2.05B
18.09x2.32x11.23x4.1x9.64x11.26x0.51% 76.15B
22.95x3.46x1.25x4.92x14.38x18.3x0.65% 48.89B
36.16x7.44x0.67x12.36x23.52x27.52x-.--% 47.83B
-46.27x2.57x0.36x3.25x9.61x11.21x3.29% 41.37B
37.23x1.65x-0.98x3.36x12.07x13.84x-.--% 29.99B
55.01x4.08x-0.83x3.36x26.05x23.16x-.--% 24.23B
-6.3x4.31x-0.32x8.96x-5.6x-5.26x-.--% 21.89B
63.91x5.61x0.43x6.11x41.98x48.5x-.--% 19.25B
24.69x3.63x0.02x5.29x13.78x19.15x-.--% 17.14B
-36x-6.39x0.87x17.16x-46.97x-54.28x-.--% 15.66B
17.77x - 0.2x3.64x14.09x16.45x-.--% 11.6B
56.44x23.02x0.53x34.19x48.35x49.87x0.17% 11.5B
-104.97x11546.08x2.41x11.34x-81.23x-112.11x-.--% 11.22B
46.54x - 6.5x - - - -.--% 10.06B
12.69x1.17x0.38x1.89x7.64x10.3x2.76% 6.84B
29.58x - 1.45x7.98x21.16x25.28x0.35% 6.06B
58.85x7.27x0.86x5.73x31.69x42.68x-.--% 5.8B
-116.26x - 7.7x - - - -.--% 5.73B
-45.23x - -0.81x - - - - 5.7B
Average 5.84x 774.01x 1.59x 8.07x 7.87x 8.23x 0.41% 20.95B
Weighted average by Cap. 13.20x 344.84x 2.59x 7.04x 10.81x 12.00x 0.56%
Biopharmaceuticals